Haibing Yu

540 total citations
18 papers, 376 citations indexed

About

Haibing Yu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Haibing Yu has authored 18 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Haibing Yu's work include MicroRNA in disease regulation (2 papers), Regulation of Appetite and Obesity (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Haibing Yu is often cited by papers focused on MicroRNA in disease regulation (2 papers), Regulation of Appetite and Obesity (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Haibing Yu collaborates with scholars based in China, Macao and United States. Haibing Yu's co-authors include Yuanlin Ding, Yuqing He, Juanjuan Lin, Biyu Liang, Kai Wang, Taek‐Kyun Kim, Danli Kong, Paul Yao, Zhigang Chu and Qiongfang Ruan and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Environment International.

In The Last Decade

Haibing Yu

17 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibing Yu China 8 187 130 54 47 44 18 376
Ravichandran Jayasuriya India 12 269 1.4× 135 1.0× 86 1.6× 54 1.1× 92 2.1× 24 482
Guofei Ren China 6 171 0.9× 37 0.3× 41 0.8× 37 0.8× 74 1.7× 8 318
Darukeshwara Joladarashi United States 12 373 2.0× 173 1.3× 28 0.5× 55 1.2× 51 1.2× 23 618
Zijing Hu China 10 215 1.1× 83 0.6× 23 0.4× 60 1.3× 10 0.2× 15 424
Nooshin Shabab Iran 13 222 1.2× 173 1.3× 10 0.2× 40 0.9× 31 0.7× 27 510
Xiaojie Zhou China 13 200 1.1× 78 0.6× 10 0.2× 35 0.7× 48 1.1× 32 484
Faezeh Malakoti Iran 11 214 1.1× 100 0.8× 13 0.2× 17 0.4× 40 0.9× 19 380
Jiawei Fan China 9 150 0.8× 63 0.5× 24 0.4× 18 0.4× 33 0.8× 25 309
Marwan Almoiliqy China 11 167 0.9× 67 0.5× 10 0.2× 47 1.0× 16 0.4× 28 397

Countries citing papers authored by Haibing Yu

Since Specialization
Citations

This map shows the geographic impact of Haibing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibing Yu more than expected).

Fields of papers citing papers by Haibing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibing Yu. The network helps show where Haibing Yu may publish in the future.

Co-authorship network of co-authors of Haibing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibing Yu. A scholar is included among the top collaborators of Haibing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibing Yu. Haibing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Li, Mingzi, et al.. (2024). Obesity aggravates the role of C‐reactive protein on knee pain: A cross‐sectional analysis with NHANES data. Immunity Inflammation and Disease. 12(9). e1371–e1371. 1 indexed citations
3.
Wang, Shihong, et al.. (2024). Association between vitamin C in serum and trouble sleeping based on NHANES 2017–2018. Scientific Reports. 14(1). 9727–9727. 6 indexed citations
4.
Wang, Shu, Rong Chen, Shuang Wang, et al.. (2023). Comparative study on risk prediction model of type 2 diabetes based on machine learning theory: a cross-sectional study. BMJ Open. 13(8). e069018–e069018. 3 indexed citations
5.
Zhang, Yang, Rong Chen, Ling Luo, et al.. (2022). Association analysis of SOCS3, JAK2 and STAT3 gene polymorphisms and genetic susceptibility to type 2 diabetes mellitus in Chinese population. Diabetology & Metabolic Syndrome. 14(1). 4–4. 12 indexed citations
6.
Pan, Haiyan, Yuanlin Ding, Xingjie Wang, et al.. (2021). LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis. Cancer Cell International. 21(1). 7–7. 37 indexed citations
7.
Yu, Haibing, Jialu Huang, Ling Luo, et al.. (2021). Association Analysis of LEP Signaling Pathway with Type 2 Diabetes Mellitus in Chinese Han Population from South China. BioMed Research International. 2021(1). 5517364–5517364. 1 indexed citations
8.
Xue, Lei, Qinglian He, Ziqi Li, et al.. (2021). Cancer stem cells in colorectal cancer and the association with chemotherapy resistance. Medical Oncology. 38(4). 43–43. 35 indexed citations
9.
Yu, Haibing, Jialu Huang, Jian Xu, et al.. (2021). Association between Single Nucleotide Polymorphism rs9891119 of STAT3 Gene and the Genetic Susceptibility to Type 2 Diabetes in Chinese Han Population from Guangdong. Journal of Healthcare Engineering. 2021. 1–5. 1 indexed citations
10.
Huang, Zhigang, et al.. (2021). Recommended confidence intervals for the conditional odds ratio in matched-pairs designs. Journal of Biopharmaceutical Statistics. 31(3). 339–351. 2 indexed citations
11.
Yu, Haibing, Wei Hu, Ling Luo, et al.. (2021). Polymorphisms analysis for association between ADIPO signaling pathway and genetic susceptibility to T2DM in Chinese han population. Adipocyte. 10(1). 463–474. 1 indexed citations
12.
Xiao, Qin, Haibing Yu, & Xiao Zhu. (2020). The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis. Infection Genetics and Evolution. 85. 104423–104423. 18 indexed citations
13.
Li, Min, Haibing Yu, Haiyan Pan, et al.. (2019). Nrf2 Suppression Delays Diabetic Wound Healing Through Sustained Oxidative Stress and Inflammation. Frontiers in Pharmacology. 10. 1099–1099. 110 indexed citations
14.
Zhong, Zhangfeng, Haibing Yu, Shengpeng Wang, Yitao Wang, & Liao Cui. (2018). Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells. Chinese Medicine. 13(1). 44–44. 21 indexed citations
16.
Pan, Haiyan, Tao Li, Zhigang Huang, et al.. (2017). Laparoscopic versus opengastric surgery for the treatment of pathological T1N0M0 gastric cancer in elderly patients: a matched study. Scientific Reports. 7(1). 12811–12811. 4 indexed citations
17.
He, Yuqing, Yuanlin Ding, Biyu Liang, et al.. (2017). A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 18(3). 456–456. 107 indexed citations
18.
Yu, Haibing, Hongyu Zhang, Zhigang Chu, et al.. (2017). Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species. Oncotarget. 8(37). 61646–61661. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026